Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Consistent Dividend Stocks to Buy Right Now

In this article, we will take a look at the 5 Best Consistent Dividend Stocks to Buy Right Now. For deeper discussion and analysis, have a look at the 15 Best Consistent Dividend Stocks to Buy Right Now. 

5. McKesson Corporation (NYSE:MCK)

Number of Hedge Fund Holders: 72

On April 6, BofA analyst Allen Lutz lowered the firm’s price recommendation on McKesson Corporation (NYSE:MCK) to $1,000 from $1,040. It reiterated a Buy rating on the shares. The analyst said the rapid decline in cash-pay GLP-1 prices is shifting prescriptions away from insurance. At the same time, strong growth in cash-pay scripts for Wegovy and Zepbound could weigh on McKesson’s FY27 EBIT guidance in the Prescription Technology Solutions segment, potentially coming in below Street expectations.

Earlier in March, the company said Britt Vitalone, Executive Vice President and Chief Financial Officer, has decided to retire after a 20-year career with McKesson, including more than eight years as CFO. Kenny Cheung is set to join the company as Executive Vice President and CFO, effective May 29, 2026.

Vitalone will remain involved with McKesson after stepping down as CFO. He will serve as a strategic advisor to help ensure a smooth transition and to support the planned separation of McKesson’s Medical Surgical Solutions business.

McKesson Corporation (NYSE:MCK) operates as a diversified healthcare services company focused on improving patient outcomes. Its US Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter drugs, along with other healthcare-related products across the United States.

4. The Sherwin-Williams Company (NYSE:SHW)

Number of Hedge Fund Holders: 83

On April 1, Citi lowered its price recommendation on The Sherwin-Williams Company (NYSE:SHW) to $385 from $410. It reiterated a Buy rating on the shares. The firm said a spike in oil prices, along with supply disruptions, has affected most key raw materials used in coatings.

Earlier, on March 19, RBC Capital also lowered its price goal on SHW to $376 from $390 and maintained an Outperform rating. The analyst noted that the company’s end markets still appear choppy. If the Iran conflict stretches beyond 8 to 12 weeks, it could weigh on Q2 margins, the analyst said in a research note. RBC also said the company’s capital allocation approach, with a focus on buybacks, remains unchanged.

The Sherwin-Williams Company (NYSE:SHW) manufactures, develops, distributes, and sells paint, coatings, and related products. It serves professional, industrial, commercial, and retail customers, mainly across North and South America, with additional operations in the Caribbean, Europe, Asia, and Australia.

3. The Coca-Cola Company (NYSE:KO)

Number of Hedge Fund Holders: 87

On March 30, Deutsche Bank raised its price recommendation on The Coca-Cola Company (NYSE:KO) to $86 from $83. It reiterated a Buy rating on the shares. The firm said it sees “legitimate and widespread pressures building” across much of the consumer packaged goods industry, tied to the conflict in the Middle East. It also noted that these stocks underperformed in March, as investors reacted to cost inflation concerns, the risk of demand trade-down, and unfavorable currency moves, the analyst said.

On April 2, CNBC reported that Coca-Cola launched a new campaign aimed at boosting soda sales at restaurants, where traffic and spending have remained under pressure. For the first time, the ads feature multiple restaurant partners. They show customers placing orders that all end with “And a Coke.” Thirteen chains are part of the campaign.

The effort comes as restaurants deal with fewer visits and lower spending, making high-margin beverages more important for profitability. Coca-Cola has also supported its partners through bundled deals and marketing initiatives to help drive demand. The campaign will run across theaters, TV, digital platforms, and delivery apps. Restaurants did not pay to participate, which reflects Coca-Cola’s role as a business partner.

About half of the company’s revenue comes from away-from-home channels, making this segment important. In North America, sales rose 4% in 2025, though volumes dipped slightly. The company expects modest growth in 2026.

The Coca-Cola Company (NYSE:KO) operates as a global beverage business. It reports across segments, including Europe, the Middle East and Africa, Latin America, North America, Asia Pacific, and Bottling Investments. Its portfolio includes sparkling soft drinks such as Coca-Cola, Sprite, and Fanta, along with other beverage categories sold worldwide.

2. Exxon Mobil Corporation (NYSE:XOM)

Number of Hedge Fund Holders: 98

On April 2, Citi analyst Alastair Syme raised Exxon Mobil Corporation’s (NYSE:XOM) price recommendation to $175 from $150. It reiterated a Neutral rating on the shares. The firm pointed to the Middle East conflict as a key factor. It believes the situation could lower the cost of equity for oil and gas stocks, which in turn is pushing price targets higher across the sector. The analyst also said the war could drive “structural re-engagement” from investors back into energy, according to a research note. Citi highlighted TotalEnergies, ConocoPhillips, and BP as its top picks.

On March 30, Reuters reported that Golden Pass LNG, a joint venture between QatarEnergy and Exxon Mobil, produced its first liquefied natural gas at its Texas facility. It marks an important step toward bringing the large US export project online. The company expects to ship its first cargo in the second quarter. At the same time, global gas supplies have been tightening, as the war in the Middle East has disrupted output in Qatar, one of the world’s largest LNG suppliers.

QatarEnergy owns 70% of the project, while Exxon holds the remaining 30%. The first production unit, Train 1, will add 6 mtpa of LNG capacity. Based on that split, QatarEnergy will receive just over 4 mtpa, and Exxon just under 2 mtpa. Exxon said the milestone reflects steady progress toward full operations, along with its continued focus on safety.

Exxon Mobil Corporation (NYSE:XOM) remains one of the largest publicly traded energy companies in the world. It operates across the full chain, from exploration and production to refining and petrochemicals, while continuing to focus on improving efficiency and lowering costs.

1. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 100

On April 6, JPMorgan analyst Chris Schott raised the firm’s price recommendation on Merck & Co., Inc. (NYSE:MRK) to $135 from $125. It reiterated an Overweight rating, heading into the April 30 earnings report. The firm is not looking for major surprises this quarter. The focus, in its view, remains on Merck’s pipeline. It also continues to see a favorable risk and return setup for the stock, especially with key data readouts expected in 2026 and 2027.

On April 2, Merck said KEYTRUDA, used with paclitaxel, with or without bevacizumab, has been approved in the European Union. The treatment is for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 with a Combined Positive Score (CPS) ≥1 and who have received one or two prior systemic therapies.

The approval also includes KEYTRUDA SC, known as KEYTRUDA QLEXTM (pembrolizumab and berahyaluronidase alfa-pmph) in the US. Merck said this makes the regimen the first and only PD-1 inhibitor-based option for eligible patients with platinum-resistant ovarian cancer in the EU. The decision allows the treatment to be marketed across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. The timing of availability in each country will depend on local reimbursement processes.

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company focused on prescription medicines, including biologics, vaccines, and animal health products. Its Pharmaceutical segment covers human health medicines and vaccines.

While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Cheapest Stocks with Highest Dividends and 14 Cheap DRIP Stocks to Buy Now

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.